MarketHMGCS2
Company Profile

HMGCS2

3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) is an enzyme in humans that is encoded by the HMGCS2 gene.

Clinical significance
Mutations in this gene are associated with mitochondrial HMG-CoA synthase deficiency (also known as HMGCS2D), affecting ketone body synthesis. Affected patients are unable to perform ketogenesis during starvation and times of higher energy need such as fever and vigorous exercise. Commonly found is damage to heart muscles and the brain, along with hypoglycemia (not always present) and elevated blood fatty acid concentration. The mortality rate is 20%. Urine organic acid analysis can be used to detect likely cases, which can be further confirmed using DNA sequencing. == Occurrence ==
Occurrence
HMGCS2 deficiency is a rare disorder in humans, with fewer than 20 patients reported worldwide == References ==
tickerdossier.comtickerdossier.substack.com